Obesity management in Prader-Willi syndrome
- PMID: 25962207
Obesity management in Prader-Willi syndrome
Abstract
Prader-Willi Syndrome (PWS) is one of the most common genetic causes of obesity. The phenotype of obesity in PWS is unique and characterized by hyperphagia, earlier meal initiation, delayed meal termination, reduced energy expenditure, abnormal gut hormone profiles, as well as irregular responses to food in areas of the brain associated with satiety and reward. Management of obesity is necessary to avoid major morbidity. The relentless food-seeking behavior associated with PWS such as stealing, hoarding food, eating inedibles, and lying about eating, can cause turmoil both inside and outside of the home. Management is challenging for both patients and caretakers, but at this time there are limited medical therapies available besides dietary restriction and behavior management. However, current research shows promise for discovery of additional treatment options for hyperphagia and obesity management in PWS.
Similar articles
-
Mechanisms of obesity in Prader-Willi syndrome.Pediatr Obes. 2018 Jan;13(1):3-13. doi: 10.1111/ijpo.12177. Epub 2016 Nov 10. Pediatr Obes. 2018. PMID: 27863129 Review.
-
Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome.Am J Med Genet B Neuropsychiatr Genet. 2016 Mar;171B(2):266-75. doi: 10.1002/ajmg.b.32401. Epub 2015 Nov 21. Am J Med Genet B Neuropsychiatr Genet. 2016. PMID: 26590516 Free PMC article. Clinical Trial.
-
Development of the eating behaviour in Prader-Willi Syndrome: advances in our understanding.Int J Obes (Lond). 2011 Feb;35(2):188-97. doi: 10.1038/ijo.2010.139. Epub 2010 Aug 3. Int J Obes (Lond). 2011. PMID: 20680019 Review.
-
In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.Neuropeptides. 2011 Aug;45(4):301-7. doi: 10.1016/j.npep.2011.06.001. Epub 2011 Jul 1. Neuropeptides. 2011. PMID: 21722955
-
High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.J Clin Endocrinol Metab. 2002 Dec;87(12):5461-4. doi: 10.1210/jc.2002-020871. J Clin Endocrinol Metab. 2002. PMID: 12466337
Cited by
-
Variability and change over time of weight and BMI among adolescents and adults with Prader-Willi syndrome: a 6-month text-based observational study.Orphanet J Rare Dis. 2020 Sep 3;15(1):233. doi: 10.1186/s13023-020-01504-7. Orphanet J Rare Dis. 2020. PMID: 32883323 Free PMC article.
-
The effects of Bifidobacterium animalis ssp. lactis B94 on gastrointestinal wellness in adults with Prader-Willi syndrome: study protocol for a randomized controlled trial.Trials. 2018 Apr 27;19(1):256. doi: 10.1186/s13063-018-2648-x. Trials. 2018. PMID: 29703235 Free PMC article.
-
Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches.Curr Pediatr Rev. 2016;12(2):136-66. doi: 10.2174/1573396312666151123115250. Curr Pediatr Rev. 2016. PMID: 26592417 Free PMC article. Review.
-
Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update.Curr Pediatr Rev. 2019;15(4):207-244. doi: 10.2174/1573396315666190716120925. Curr Pediatr Rev. 2019. PMID: 31333129 Free PMC article. Review.
-
Obesity management in Prader-Willi syndrome: current perspectives.Diabetes Metab Syndr Obes. 2018 Oct 4;11:579-593. doi: 10.2147/DMSO.S141352. eCollection 2018. Diabetes Metab Syndr Obes. 2018. PMID: 30323638 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical